Images List Premium Download Classic

Prostate Cancer

Prostate Cancer-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Materials and methods for detecting androgen receptor splice variants and uses thereof
University Of Washington
January 11, 2018 - N°20180011101

The present disclosure relates to materials and methods for evaluating prostate cancer using binding entities (such as antibodies) that bind to the n-terminus and the c-terminus of androgen receptor. Prostate samples are histochemically labeled for the n-terminus and the c-terminus of androgen receptor, and a ratio between the binding of the n- and c-terminal antibodies is determined.
Id4 protein restores wild type p53 activity
Clark Atlanta University
January 11, 2018 - N°20180008669

A compound and method for treating cancer, in particular prostate cancer. Id4 reverts mutant p53 activity to its wild type physiological status and activity. Id4 or its peptidemimatics are used to revert mutant p53 to wild type p53, restoring its tumor suppressor activity.
Mirna-based predictive models for diagnosis and prognosis of prostate cancer
University Of Freiburg
January 04, 2018 - N°20180002762

The lack of clear predictors of prostate cancer progression leads to subjective decision-making regarding courses of treatment. The identification of new biomarkers that are predictive of recurrence after radical prostatectomy would advance the field of prostate cancer treatment. Disclosed are mirnas that can be used as molecular biomarkers to detect or predict the progression of prostate cancer and to adjust ...
Prostate Cancer Patent Pack
Download 215+ patent application PDFs
Prostate Cancer Patent Applications
Download 215+ Prostate Cancer-related PDFs
For professional research & prior art discovery
inventor
  • 215+ full patent PDF documents of Prostate Cancer-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Double targeted constructs to affect tumor kill
December 28, 2017 - N°20170368005

Or pharmaceutically acceptable salts thereof. The present technology is especially well-suited for use in treating prostate cancer.
Selective androgen receptor degrader (sard) ligands and methods of use thereof
University Of Tennessee Research Foundation
December 28, 2017 - N°20170368003

This invention is directed to pyrrole, pyrazole, imidazole, triazole, and morpholine based selective androgen receptor degrader (sard) compounds including heterocyclic anilide rings and their synthetic precursors, r-isomers, and non-hydroxylated and/or non-chiral propanamides, and pharmaceutical compositions and uses thereof in treating prostate cancer, advanced prostate cancer, castration resistant prostate cancer, triple negative breast cancer, other cancers expressing the androgen receptor, ...
Use of methylation sites in y chromosome as prostate cancer diagnosis marker
Beijing Institute Of Genomics, Chinese Academy Of Sciences
December 21, 2017 - N°20170362663

Disclosed is a use of methylation sites as a disease diagnosis marker, in particular relating to a use of methylation sites in a y chromosome as a prostate cancer diagnosis marker. More particularly, the method and criterion for screening methylation sites in chromosomes associated with a disease are established in the present invention, and using prostate cancer as an example, ...
Prostate Cancer Patent Pack
Download 215+ patent application PDFs
Prostate Cancer Patent Applications
Download 215+ Prostate Cancer-related PDFs
For professional research & prior art discovery
inventor
  • 215+ full patent PDF documents of Prostate Cancer-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Novel sustained release polymer
Tolmar Therapeutics, Inc.
December 21, 2017 - N°20170362377

A polymer and a method for its preparation are provided. The polymer comprises poly(lactide), poly(lactide/glycolide) or poly(lactic acid/glycolic acid) segments bonded by ester linkages to both ends of an alkanediol core unit. The polymer is for use in a controlled release formulation for a medicament, preferably leuprolide acetate. The controlled release formulation is administered to ...
Method of preventing or reducing the progression of prostate cancer
Nymox Corporation
December 21, 2017 - N°20170360885

The embodiments include methods of preventing or reducing the progression of prostate cancer in mammals susceptible to developing prostate cancer, and to methods of reducing the incidence of clinically detected prostate cancer, using compositions containing compounds based on small peptides and a pharmaceutically acceptable carrier. The method includes, but is not limited to, administering the compounds intramuscularly, orally, intravenously, intraprostatically, ...
Anticancer compositions
Aragon Pharmaceuticals, Inc.
December 21, 2017 - N°20170360754

The present invention concerns pharmaceutical formulations of arn-509, which can be administered to a mammal, in particular a human, suffering from an androgen receptor (ar)-related disease or condition, in particular cancer, more in particular prostate cancer, including but not limited to castration-resistant prostate cancer, metastatic castration resistant prostate cancer, chemotherapy-naive metastatic castration resistant prostate cancer, biochemically relapsed hormone sensitive ...
Anticancer compositions
Aragon Pharmaceuticals, Inc.
December 21, 2017 - N°20170360713

The present invention concerns pharmaceutical formulations of arn-509, which can be administered to a mammal, in particular a human, suffering from an androgen receptor (ar)-related disease or condition, in particular cancer, more in particular prostate cancer, including but not limited to castration-resistant prostate cancer, metastatic castration resistant prostate cancer, chemotherapy-naive metastatic castration resistant prostate cancer, biochemically relapsed hormone sensitive ...
Anticancer compositions
Aragon Pharmaceuticals, Inc.
December 21, 2017 - N°20170360707

The present invention concerns pharmaceutical formulations of arn-509, which can be administered to a mammal, in particular a human, suffering from an androgen receptor (ar)-related disease or condition, in particular cancer, more in particular prostate cancer, including but not limited to castration-resistant prostate cancer, metastatic castration resistant prostate cancer, chemotherapy-naive metastatic castration resistant prostate cancer, biochemically relapsed hormone sensitive ...
Psma-targeting imaging agents
December 14, 2017 - N°20170354748

Are described, wherein s1 is an organic spacer group having from 5 to 30 carbons, a is an amino acid forming a portion of a negatively charged peptide oligomer, n is from 3 to 6, s2 is an organic spacer group having from 5 to 15 carbons, and i is an imaging group, and pharmaceutically acceptable salts thereof. The psma-specific imaging agents can be used to ...
Combinatorial androgen deprivation with an androgen receptor vaccine
Wisconsin Alumni Research Foundation
December 14, 2017 - N°20170354725

It is disclosed herein methods of treating prostate cancer comprising administering to the subject the combination of androgen deprivation therapy (adt) and a vaccine directed against the androgen receptor or a fragment of the androgen receptor. Also disclosed are methods of increasing the efficacy of androgen deprivation therapy in a subject with prostate cancer comprising administering to the subject an ...
Prostate Cancer Patent Pack
Download 215+ patent application PDFs
Prostate Cancer Patent Applications
Download 215+ Prostate Cancer-related PDFs
For professional research & prior art discovery
inventor
  • 215+ full patent PDF documents of Prostate Cancer-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Diagnosis and monitoring treatement of prostate cancer
The General Hospital Corporation
December 07, 2017 - N°20170350896

Provided herein are assays and methods related to determining a ratio of expression levels of psa/psma or determining the expression level of psma in circulating tumor cells for diagnosis and/or for the purpose of monitoring treatment efficacy for prostate cancers that are likely hormone resistant.
A dna-methylation test for prostate cancer
University College Dublin National University Of Ireland, Dublin
December 07, 2017 - N°20170349952

A method of determining the risk of metastatic prostate cancer in an individual diagnosed with prostate cancer, the method comprising a step of assaying a biological sample obtained from the individual for the presence of at last one methylated regulatory dna sequence selected from group comprising: sequence id no's 1 to 16, or variants thereof, and correlating the presence or absence of ...
N-(4-hydroxy-4-methyl-cyclohexyl)-4-phenyl-benzenesulfonamide and n-(4-hydroxy-4-methyl-cyclohexyl)-4-(2-pyridyl)-benzenesulfonamide compounds and ...
Pimco 2664 Limited
December 07, 2017 - N°20170349551

The present invention pertains generally to the field of therapeutic compounds. More specifically the present invention pertains to certain substituted n-(4-hydroxy-4-methyl-cyclohexyl)-4-phenyl-benzenesulfonamide and n-(4-hydroxy-4-methyl-cyclohexyl)-4-(2-pyridyl)benzenesulfonamide compounds (collectively referred to herein as hmc compounds) that are useful, for example, in the treatment of disorders (e. G., diseases) including, inflammation and/or joint destruction ...
Drug delivery polymers and uses thereof
Massachusetts Institute Of Technology
December 07, 2017 - N°20170348431

Described herein are platinum-based brush-arm star polymers (pt-basps), or a pharmaceutical composition thereof, for delivery of platinum-based agents, such as oxaliplatin. Also provided are methods and kits involving the pt-basps, or a pharmaceutical composition thereof, for treating proliferative diseases such as cancers (e. G., lung cancer, head-and-neck cancer, esophagus cancer, stomach cancer, breast cancer, pancreas cancer, colorectal cancer, liver cancer, ...
Method for ameliorating and abating symptoms resulting from rheumatoid arthritis, fibromyalgia, and chronic pain of ...
Honor C.w. M.d., Llc
December 07, 2017 - N°20170348412

The present invention provides a composition and method for treating diseases associated with demyelination of the nerves, such as als, ra, tremors/parkinson's disease, and ms, alzheimer's disease, als, guillain-barre syndrome, atherosclerosis, schizophrenia, tremors/parkinson's disease, senile dementia, muscular dystrophy, attention deficit disorder, attention deficit hyperactivity disorder, complex regional pain syndrome, diabetes, neuropathic pain, spider arthritis west nile virus,, fibromyalgia, ...
Method of diagnosing and treating prostate cancer
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College
November 30, 2017 - N°20170343551

A method of diagnosing a potentially lethal prostate cancer in a patient comprising measuring one of a level of sam pointed domain containing ets transcription factor (spdef) expression in the patient, a level of twist1 protein in the patient, and a level of matrix metalloproteinase 9 (mmp-9) expression in the patient, and diagnosing the patient with potentially lethal prostate cancer if ...
Arteriosclerosis and cancer detection method using deoxyhypusine synthase gene as indicator
National University Corporation Chiba University
November 30, 2017 - N°20170343547

The present inventors have surprisingly found that a deoxyhypusine synthase (dhps) gene, which was previously reported to correlate with prostate cancer and cervical cancer, is highly responsive to arteriosclerosis or digestive system cancer, whereby the gene can be used as a desired marker for arteriosclerosis or digestive system cancer. The present invention has been accomplished on the basis of this ...
Diagnosis of prostate cancer
Quest Diagnostics Investments Incorporated
November 30, 2017 - N°20170342402

The invention provides methods for isolating rna from whole urine and urine fractions for the diagnosis of prostate cancer and/or benign prostate hyperplasia. An exemplary method for diagnosing prostate cancer in an individual, said method comprises: (a) determining the amount of rna encoding one or more diagnostic genes in the soluble urine fraction of a urine sample obtained from ...
Loading